<SEC-DOCUMENT>0000950170-23-045111.txt : 20230829
<SEC-HEADER>0000950170-23-045111.hdr.sgml : 20230829
<ACCEPTANCE-DATETIME>20230829171423
ACCESSION NUMBER:		0000950170-23-045111
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230829
ITEM INFORMATION:		Other Events
FILED AS OF DATE:		20230829
DATE AS OF CHANGE:		20230829

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FIBROGEN INC
		CENTRAL INDEX KEY:			0000921299
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36740
		FILM NUMBER:		231223034

	BUSINESS ADDRESS:	
		STREET 1:		409 ILLINOIS STREET
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94158
		BUSINESS PHONE:		415-978-1200

	MAIL ADDRESS:	
		STREET 1:		409 ILLINOIS STREET
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94158
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>fgen-20230829.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?><!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2023-08-29T17:12:05.3562+00:00 --><!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:fgen="http://www.fibrogen.com/20230829" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html" />
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_beb34137-bb04-4096-aa07-7311cadeb5a7" name="dei:EntityCentralIndexKey" contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9">0000921299</ix:nonNumeric><ix:nonNumeric id="F_a7453f1c-9db3-4812-b92c-e02400149aac" name="dei:AmendmentFlag" contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="fgen-20230829.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C_d206cde4-4b9b-485e-8579-ab78929ad8a9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000921299</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-29</xbrli:startDate><xbrli:endDate>2023-08-29</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <p style="border-top:2.25pt double rgba(0,0,0,1);text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">UNITED STATES<br />SECURITIES AND EXCHANGE COMMISSION<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FORM </span><span style="font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_4ef35b19-b843-44e9-8b2d-e167e98e1ab3" contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9" name="dei:DocumentType"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CURRENT REPORT</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.02986111111111111in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_524b0d53-1ce6-4f06-b8ee-d906c5c9ec87" contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">August 29, 2023</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:5.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:24.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_03a3d11d-ecf8-48e5-acb9-fc81e768078a" contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9" name="dei:EntityRegistrantName"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:24.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FIBROGEN, INC.</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:20.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:20.0%;"></td>
    <td style="width:18.0%;"></td>
    <td style="width:41.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_2e2c95ea-1657-41a7-86ee-ee62e60ef440" contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_33357f6a-7b97-4aaa-82cb-5b9c59f64da3" contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9" name="dei:EntityFileNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">001-36740</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_ad69a749-17e8-4a12-8755-71d5b18d841c" contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9" name="dei:EntityTaxIdentificationNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">77-0357827</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(State or Other Jurisdiction<br />of Incorporation)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Commission File Number)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(IRS Employer<br />Identification No.)</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a2fd74d1-8699-426f-818a-653079268244" contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9" name="dei:EntityAddressAddressLine1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">409 Illinois Street</span></ix:nonNumeric></span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9810c3fb-fb26-4c41-8b2e-c16c3f3a2042" contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9" name="dei:EntityAddressCityOrTown"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">San Francisco</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_8a4b0c5a-4de8-41a6-857d-4bcde7089082" contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">California</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1384b403-87c4-43ed-9f41-12e3b1efc70d" contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9" name="dei:EntityAddressPostalZipCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">94158</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.125in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.02986111111111111in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registrant&#x2019;s Telephone Number, Including Area Code:</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_14629135-9e2a-44f6-8210-1960e193941f" contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9" name="dei:CityAreaCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">415</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9312dff3-89cb-4b31-b34a-00c07af1b760" contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9" name="dei:LocalPhoneNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">978-1200 </span></ix:nonNumeric></span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.125in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:9.0pt;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_57b17cc0-29a6-4723-8ed3-2404c0a1f3a7" contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6.0pt;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_abe58744-cf71-458d-adf3-8fc384c1d097" contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6.0pt;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a26eeb9c-c69b-42ac-a9d3-8208e7659fa8" contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6.0pt;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_460923e6-d8a5-41d8-845a-d48a02ce58cb" contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:9.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:38.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:15.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:45.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br />Title of each class</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trading<br />Symbol(s)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br />Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b2860430-d1cb-4743-bdbe-80466844fcfd" contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9" name="dei:Security12bTitle"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock, $0.01 par value</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5eb61462-ba3e-4b01-93d5-c0fd1bfd9d84" contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9" name="dei:TradingSymbol"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FGEN</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_af9f164b-bd45-43ae-8763-98acb6747dfb" contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Nasdaq Global Select Market</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#x202f;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#x202f;240.12b-2 of this chapter).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Emerging growth company </span><span style="font-size:10.0pt;"><ix:nonNumeric id="F_dd5b44da-e1cc-4be7-8f72-3519f2549845" contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:2.25pt double rgba(0,0,0,1);text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 8.01 Other Events.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On August 29, 2023, FibroGen, Inc. issued a press release in which it reported topline results from its Phase 3 study of pamrevlumab for the treatment of Duchenne muscular dystrophy in ambulatory patients.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A copy of such press release is furnished as Exhibit 99.1 to this report and is incorporated herein by reference.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d) Exhibits</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:1.0%;"></td>
    <td style="width:10.083%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:87.917%;"></td>
   </tr>
   <tr style="height:3.3pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br /><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:12.15pt;">
    <td colspan="2" style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid rgba(0,0,0,1);text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit No.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid rgba(0,0,0,1);text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="height:3.3pt;">
    <td colspan="2" style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:24.75pt;">
    <td colspan="2" style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">99.1</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="fgen-ex99_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Press Release titled &#x201c;FibroGen Announces Topline Results from LELANTOS-2, a Phase 3 Clinical Study of Pamrevlumab in Ambulatory Duchenne Muscular Dystrophy</span></a><a href="fgen-ex99_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; dated August 29, 2023</span></a></p></td>
   </tr>
   <tr style="height:24.75pt;">
    <td colspan="2" style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">104</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SIGNATURES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:6.0%;"></td>
    <td style="width:44.0%;"></td>
    <td style="width:4.0%;"></td>
    <td style="width:46.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:4.3pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FIBROGEN, INC.</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">August 29, 2023</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Michael Lowenstein</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Michael Lowenstein<br />Chief Legal Officer</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>fgen-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><img src="img3914235_0.gif" alt="img3914235_0.gif" style="width:185px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:14.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:14.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">FibroGen Announces Topline Results from LELANTOS-2, a Phase 3 Clinical Study of Pamrevlumab in Ambulatory Duchenne Muscular Dystrophy</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:14.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;">&#x2013; Study did not meet the primary endpoint &#x2013;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:14.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;">&#x2013; Pamrevlumab was generally safe and well tolerated &#x2013;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">SAN FRANCISCO, August 29, 2023 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced topline data from the Phase 3 LELANTOS-2 trial of pamrevlumab for the treatment of ambulatory patients with Duchenne muscular dystrophy (DMD) on background systemic corticosteroids.  The study did not meet the primary endpoint of change in the North Star Ambulatory Assessment (NSAA) total score from baseline to week 52 (placebo-corrected mean difference -0.528 points; 95% CI -2.308 to 1.251; p=0.5553). Secondary endpoints measured by change from baseline at week 52 in 4-stair climb velocity, 10-meter walk/run test, time to stand, time to loss of ambulation, and proportion of patients with greater than 10 seconds in the 10-meter walk/run test were also not met.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201c;We are deeply disappointed that the LELANTOS-2 study did not meet its primary endpoint,&#x201d; said Thane Wettig, Interim Chief Executive Officer, FibroGen.  &#x201c;We are grateful for the courageous efforts of patients, their caregivers, the advocacy community, and the trial investigators who have contributed to this important clinical study.  We are committed to sharing all learnings from this trial with the Duchenne community and hope that there are insights that may help future efforts to develop treatments for this devastating disease.&#x201d;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Preliminary safety data showed that pamrevlumab was generally safe and well tolerated.  The majority of treatment emergent adverse events were mild or moderate.  Treatment-emergent serious adverse events were observed in 8.3% of patients in the pamrevlumab group and 2.8% of patients in the placebo group.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">FibroGen is in the process of evaluating the totality of the data, including other pre-specified endpoints, to determine the next steps for the program.  The Company plans to communicate the full results of the LELANTOS-2 study at an upcoming medical forum.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">About LELANTOS-2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">A total of 73 boys with ambulatory DMD ages 6 to &lt;12 years were enrolled in LELANTOS-2, a global, Phase 3, randomized, double-blind trial of pamrevlumab or placebo in combination with systemic corticosteroids.  The primary endpoint of the study was ambulatory function measured by change in the North Star Ambulatory Assessment (NSAA) total score from baseline to Week 52.  Secondary endpoints assessed from baseline to Week 52 included changes in 4-stair climb velocity, 10-meter walk/run test, time to stand, time to loss of ambulation, and proportion of patients with greater than 10 seconds in the 10-meter walk/run</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">test.  In LELANTOS-2, patients were dosed with pamrevlumab (35 mg/kg IV on Day 1 and every two weeks thereafter with last dose at Week 52) or placebo.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">About Duchenne Muscular Dystrophy </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br></font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Duchenne muscular dystrophy (DMD) is a rare and debilitating neuromuscular disease that affects approximately 1 in every 5,000 newborn boys.  About 20,000 children are diagnosed with DMD globally each year.  The fatal disease is caused by a genetic mutation leading to the absence or defect of dystrophin, a protein necessary for normal muscle function.  The absence of dystrophin results in muscle weakness, muscle loss, fibrosis, and inflammation. Patients with DMD are often wheelchair-bound before the age of 12, and their progressive muscle weakness may lead to serious medical problems relating to respiratory and cardiac muscle.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">About Pamrevlumab</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Pamrevlumab is a potential first-in-class antibody being developed by FibroGen to inhibit the activity of connective tissue growth factor (CTGF), a common factor in fibrotic and proliferative disorders characterized by persistent and excessive scarring that can lead to organ dysfunction and failure.  Pamrevlumab is in Phase 3 clinical development for the treatment of ambulatory Duchenne muscular dystrophy (DMD), and locally advanced unresectable pancreatic cancer (LAPC), and in Phase 2/3 for the treatment of metastatic pancreatic cancer. The U.S. Food and Drug Administration has granted Orphan Drug Designation to pamrevlumab for treatment of patients with DMD and pancreatic cancer, and Fast Track designation to pamrevlumab for the treatment of patients with DMD and LAPC. The U.S. Food and Drug Administration has also granted Rare Pediatric Disease Designation to pamrevlumab for the treatment of patients with DMD.  Pamrevlumab has demonstrated a safety and tolerability profile that has supported ongoing clinical investigation in DMD, LAPC, and metastatic pancreatic cancer. Pamrevlumab is an investigational drug and not approved for marketing by any regulatory authority. For information about our pamrevlumab studies please visit www.clinicaltrials.gov.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="color:rgba(121,121,121,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">About FibroGen</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">FibroGen, Inc. is a biopharmaceutical company committed to discovering, developing, and commercializing a pipeline of first-in-class therapeutics.  The Company applies its pioneering expertise in connective tissue growth factor (CTGF) biology and hypoxia-inducible factor (HIF) to advance innovative medicines for the treatment of unmet needs.  Pamrevlumab, a fully human anti-CTGF monoclonal antibody, is in clinical development for the treatment of locally advanced unresectable pancreatic cancer (LAPC), metastatic pancreatic cancer, and ambulatory Duchenne muscular dystrophy (DMD).  Roxadustat (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x7231;&#x745e;&#x5353;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:8.040000000000001pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#174;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, EVRENZO</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:8.040000000000001pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">TM</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">) is currently approved in China, Europe, Japan, and numerous other countries for the treatment of anemia in CKD patients on dialysis and not on dialysis.  Roxadustat is in clinical development for chemotherapy-induced anemia (CIA) in China.  FibroGen recently expanded its research and development portfolio to include product candidates in the immuno-oncology space along with an exclusive license for FG-3246.  For more information, please visit www.fibrogen.com.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Forward-Looking Statements</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">This release contains forward-looking statements regarding FibroGen&#x2019;s strategy, future plans and prospects, the development and commercialization of the company&#x2019;s product candidates, the potential safety and efficacy profile of its product candidates, and the potential impact of clinical data.  These forward-looking statements include, but are not limited to, statements about FibroGen&#x2019;s plans and objectives and typically are identified by use of terms such as &#x201c;may,&#x201d; &#x201c;will&#x201d;, &#x201c;should,&#x201d; &#x201c;on track,&#x201d; &#x201c;could,&#x201d; &#x201c;expect,&#x201d; &#x201c;plan,&#x201d; &#x201c;anticipate,&#x201d; &#x201c;believe,&#x201d; &#x201c;estimate,&#x201d; &#x201c;predict,&#x201d; &#x201c;potential,&#x201d; &#x201c;continue&#x201d; and similar words, although some forward-looking statements are expressed differently. FibroGen&#x2019;s actual results may differ materially from those indicated in these forward-looking statements due to risks and uncertainties related to the continued progress and timing of its various programs, including the enrollment and results from ongoing and potential future clinical trials, and other matters that are described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 and our Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, each as filed with the Securities and Exchange Commission (SEC), including the risk factors set forth therein.  Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release, and FibroGen undertakes no obligation to update any forward-looking statement in this press release, except as required by law.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Contacts:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">FibroGen, Inc.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Investors:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">David DeLucia, CFA</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Vice President, Corporate FP&amp;A and Investor Relations</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">ddelucia@fibrogen.com</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Media:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Michael Szumera</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">External Communications</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">mszumera@fibrogen.com</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img3914235_0.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img3914235_0.gif
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MS#.J_S/5 #/5,S/59C/5F3/5S#/5_S/_ #/_,S/_9C/_F3/_S#/__V8  &8
M,V8 9F8 F68 S&8 _V8K &8K,V8K9F8KF68KS&8K_V95 &95,V959F95F695
MS&95_V:  &: ,V: 9F: F6: S&: _V:J &:J,V:J9F:JF6:JS&:J_V;5 &;5
M,V;59F;5F6;5S&;5_V;_ &;_,V;_9F;_F6;_S&;__YD  )D ,YD 9ID F9D
MS)D _YDK )DK,YDK9IDKF9DKS)DK_YE5 )E5,YE59IE5F9E5S)E5_YF  )F
M,YF 9IF F9F S)F _YFJ )FJ,YFJ9IFJF9FJS)FJ_YG5 )G5,YG59IG5F9G5
MS)G5_YG_ )G_,YG_9IG_F9G_S)G__\P  ,P ,\P 9LP F<P S,P _\PK ,PK
M,\PK9LPKF<PKS,PK_\Q5 ,Q5,\Q59LQ5F<Q5S,Q5_\R  ,R ,\R 9LR F<R
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MC=S:SE)HX/#[<,VV=.R;$>8:G<IP__9R'_=T/_=V7_=X?_=ZG_=\O_=^W_>
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M^43X]8Y;WPLG\<K8VI^.L3=->@L7J_N:I2;7N]\%_V]XQ1N60*F(-.$I0D$
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M/:V2P'")"4/TF=!A(^KZ*KF0Q#KTPTS4Q$UL*MW)%^90AI%!+\@9LX&2P0V
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M8D!)&LPB$!2>Q BA62).-A:FR!1!25W"R@[;%:@0N0UF7R'7RCHU-9P!+XT
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M'!C#^(3^'<0/8 X29<8UF=K!'!P2F<86C=SF&<$%0D7EX< ;+$,W?83*N4<
MCL3'2 Y=.%/D#)R1.(Y#S!^\=%_Z7<NO^5K[,56L3$_<I8R.V9RM;$N0H52W
M=4CRL)GU;=G%")!$P-Y'9)FPJ%T4\D\Q^$5E"9N6,6%6.* !QJ$<MH0X*1NM
M/!=U;-NGM C:Z=REG T<)D8/P4J3W>'2H=3=V=+/%1UXC=\</B(D_T9B)'8?
MR%$(GA&$?-G$QD0@1DP<*("")MC!&UQ@!@*6XFG)PI"@,ZTB7T6.YX4;06S
M#[B@J!T8!1H8-I7&Z)&&+FH3+QH,FN!7YKV!'2@1*'S10XBA:-"%[*W@#0K)
M,% $X0B7&A$73%U54:3605C7<D373L14I 1;O&TACKS-]S%BSS55\CCB2>0>
M)8DC@DSA5NP>U/0-N; -^VA6(L86.TJB/_ZC1CB.+%T*+;6AK63?&1%=5O2C
M@PSBFJ$C2=V1%VHA_N& & (D1F:D1DK9HN% )C)([UA%7FR8,<+!&VB>%K6B
ME@ C<!C1Y9R&R8E)FOP ,8(B'#@.9X$'ZO^@1#30P\0)T9>X9$MB4X+Y(NF5
MFIG@XL*0U@N.XB="G@V*!&8H($P,D2\6232) 3@%3DAB(9K%VCF"ED)T%UF*
M 0>=I5F*P4"A97<-E%NF95N:I2BEY5NN)5W*95G6)5S>)5OBI5^6)5N*TEP"
MIEH69E[N)6'&95\FIF&:Y5JNY5Q>9..96$]ME?.!%R4 QM3!XCARX1P%XD:&
MIOF]2MQEBMP)7?:(B^^55S[&7R9LI9(82O9!H=*0%T7@XW3,4O/LF6CVIF_^
MYI3AF8\ R54P9.,]WB<6(P;ZHN@H)<*8HE J4Q(9XR?:X#+H"S&$Q30)V'7Y
MC1@8H4J PL9<'"O_:@ K%H$=@&(QOD$16,X&HDEH&%%IF&=6C 8'!J,PCJ(Q
M*@,TD(9D>L3&)-B?#4D.%L1_Y@K*H*.D#)__561\06(/O=]&89WO#,1'<A^"
M(&15P9IQ J>'XAOZ*5]J:NB-!0U;I %L$DKUZ5IJ!52CQ5C.B9U. 0]0#,.'
MWBB.YN@OZ4-:'&A>0 ]X9L3$11XHP($HEF+%O2<N/N?I;9X%IN<G*L.&D4D%
M/"-'K.%/&(>B@:7,[>1-7*!<V6(N4H!J9,0D6>AU*@.1AJ))HF1<!*%\)F4N
MKN1EC 8&6N!3.A[L7<D6A0DG/@B/3D6'GHMP 9)4N!OP2<4.FE^=\,>N.C$'
M;SE*D$K=BC%/FCF:>+AH6_BHCG8J<Q45]EG5R[ ;MHR4(MIF/W$J@PRBC>F6
MMAD?( D2:'HJK=;_JJVBRS*T&4&H:G!=A9 2J2B28N7T"X)=#NA &A<5P2A"
M:0-%0UIU!.4@$<EMA'_Y"'<FS?4,*DI 0Z !86B<8!"2QAOHRS*H3TC E[TD
MYTEN'K'^AI*.B72^9YDTI1UH N1-W$>$6NFTDT),ZLDP61(65U0 CW1XRH4*
MX#+XT'E\8QS!&LSX:W#E#&HFE:%^"CW>*L;*6;:9Q_I-;+2]DN^IS[BM2Y1X
M8[3EB&8-V4U]"J]FK,N^+,P>ASPM*F((TW5<GDKFHLX*FN(YJ9%6)S0L V^H
MQ(;)ZP90$9D9D-"PVW<2$U]0W*0I*>F-G&Y,$HA]1!UV(T@XWE..(@:V_^3H
M7-RD99,PFN13%BV83*N$&-J#'@YI&J3? $T>;N.C'.P XB2)P2VCS,"LR@26
M)EL:@5#?QBSA1A(U:D@=O1R;+!2-75]TC('3JHLR%-3*?FQY44W!6JXU&E"*
M%J[G?B[H/DBP0 1B>"*;EJ)E9(=21IJH;9Y31JF5<D1_/A-*N!7IJ2U&"">7
M7D]V$89X&MB[LN(&3(84X4#G8@2Z6J1*U X<$"DH*">2PFD*'@S99@EZ1FE4
M0H@\5:+AJ [-Y U2\!3<P=%!V.T :L(EZFH:\<<8Q.Y?(.'OM4\?QI$A4H>V
MAB[^WH]6?9D>YF$\GBK5K!]L8,W&=B'_ZM3_>;%LKXW!L^:O S\P!//%)4*L
M3'!MD:ZKI!GEP3B HYBBZ];K)U)E22Q#9N"N2/C&>Z(&)P9,=L18)D0N82Q#
M'8B>@);>;]QD-E)EU@J*2MA!9! <M#;0)UH@>VZ,Q47:7]VG95S>@NUG]@Z&
MTAGO_/QMMH1LB5HFW8I21N(MKQ6D/%Y-8;A> 9$+/&+5SK5L!*<QN^ 9-FK9
MQWU>&::%_HFL9<&PNQ@*@[:J@YGA5TJ3&O__,2 ',DSPR/UZA">"@M?.HK%:
MA@J6IYT6;R:(\$O<EZBE1+0"(<():<!@EZZ.Y>#6A93N[/2N9&;\P(J@4+;M
M:DJ('..QA 6S:>V$Z9B:'"NBB9.^KII*LDP8UD-\\J^<U7F8K/2PA]Z E"*A
M@4;6P[F)J, <+V# K[%@56R%8-H4LB!?\[D(7HD^WZS-S(LEL()2\*\,(D5B
M%1[QAW6),S:O,SL_, -.!-*IZ1 7L4QV8+@&(1*-G$FFIP/=H/V9+^)%AA&D
M1 YI$W 1U9LMQ6M*2,'$:<*0'E<<;S0,!4!KA,B9<$L@JZB)(CV[:\6AACTO
M3 DW<91&@S.CA#Y<_Z(U$RI8SE$62K- 5'0!UD,FI&\70I5P4'&)6A<G.80O
MMS-0(TF(&A6LTM&ECH7/@9\H_?22K!(\BD_14"'<KG105[55YZ@V+T642:ES
MXN+I&4%-@D(#C<2KF$5=L')*4. 6;40T6$RG>"F%<#5\*I/4!E9!<<\D_-&J
M-2-&KT0R&1CW!.TGU@$I&K%+FN)*$N5SNNY^IEY)(*,,J/._IJ9K.1FCH'/Y
M^'%OLD9W@:PTL9UBK*C,2>Q6042D6IU!4/55K[:$)&_=D>&2'0]!'N*A?!1Y
MC $:>]WQ084XVB$B@:&FL;9P#S?A?I@6E\270.<1NR!UZK)(Y.#1T85CH7A$
M[1G8O2C:&7+!"QO),N00N-9P7^4 ]SB*3$=8"=?$$/E59*1$T (K!@,6*X[M
M@94P$%\I0R"S_?0.AM1<C<T1=94W)!)#*FE")CB))IST8;@V,^LQ4Q.W@Q\&
M @(WT95*19XL.,+;P(XEXF2U-/>6SJ4=133X@X__.(D+H,58:$D4S&\XZ2>&
M0F[O0WH N$F@\)]ZQ ;$Z>W%GDWKGQBH=F&(9_7*=P6$D5L;Z$G8K@_.1!$T
M<E^KQ"&O)V0,9=B6R9\F*$$@N. 4ZFG16,TM[%N7N$JT!K1U2/%:*AWY.)BG
MN5X4G=Z"%WIDTCT]'8H9A&2WBS+@XQE6[$E!W_[A@!VK.: '^B-N\L5Z1-#Z
M!1[OAW1K1J'<9Q+M@\M%QR2(^&$@,F*'#A*7J9".%H"'"3HI-J/KA6 7:1V@
MI/0F78^H$#6Z!3]IJ/C>$JQKMJ"+!+IR\]F8*G1486S7':7/NJ_#1/(ZRSEC
M2H8X+OUV!9KS"JL.>_"-Y]>K"PJ6_[JT3[N]14-8]/I,T(=$8/L^;%B-<X38
M1H;+/9WN1?N11,,0'5SH[.P2L>T4G<0RSD3B749H' 8T3)P((P6W[PK)Z!^7
M-5U<N))$X#>U<\37E7.V.-QL@W'!-_Q>[' 6<[(W8]_=1.&AYLB^ZXIS*;"+
MI:.&,+##A[S(5YLP'<2+PX0[RCA);%B479CB<7#<P36Z@&D1K: R9=@[8T5Y
M@X9SFT10YF*3(\9;%#KB*'@33G/*Y/GIC#SR&F)I%C7'8PS33_U-(&-J638E
M88INLF&)I>$*H<'E!JPVVB-1J#S5G_\]VD=2-.& @U Q3H#.GW_$E![,6[1'
M&IR\@XCG!M8U7QD<-Q5PW -H9'!JPH0ZA/@7S4XC91Y[SP00XS=%XL_ZJG-]
M&1FB[^E>VF>^*V_N>EA% OM6K#C<)F<*WO/*6GEY0<"<EZU'G6N^Z[]^?D^%
MV>-%'2H$MBM3SU]$XJF[L(PE/6Q--(QG*\JR:!3!58AS<IN"3+C\PKAO3C-$
MY ].I/,Q^^'?L]D)U:=R-](2-WM\275^Z<,^H#M: ,L1I. C\V5]3+&%U[N0
M._:$>&Q2V22[^->__;-+(R3%[,=+)NT_0.P3.)!@A0T4""94*+#(P0T&(>*0
M@4-B11S$%F;_U+B18T>/'T%NM /1804-#RD\U$"R@D4<RD(VK  JI,<W%2":
MK%"D9D^?'8E1G(A#WT^C1Y$F_4AL* XN%"N*&2I#C,6F5ZM2G8I#JE"A5:,J
M%3N6;%FS9]&F5:II8E>O%;=:_2K79=RFFM3FU;N7;U^_?P$'%CR8<&&U0>%F
M]4H5:EN[B]_*&-/6JN*W$BU;A&F8\]DTCZ-&!0T:;V?3IU&G5KV:=6O7KV''
MECV;=NVS7(=F@JUIL9BTT5)6"+GL(<3@%+QV%8/1MF!0#Z'CC%X<^D.AND'"
M,5EZ[ :5).'05F91S++FK'E/C$MWJUOUEZ]&OISF?'W[]PEFDKM^.71CBD\Q
M$^V_Q9C#S\ #$4Q0P05MFXLNR"I[L"[_!MQ//LR&*I!!P])@#[X*UU/NH@U)
M+-'$$U%,4?_%%5EL$;]Z_--P-7KBVLPLX@P":9@*@ILNA_5L=/$G960*;B6=
M'** I!QP,.^C-QZR@RQEJ-.I FAFBV:,QK@3TBS$P!H*0-#H<L^B,2L4< PO
MV6QS'[8N<PM-]Q2;X3(/+^O2S3WY[--//^&$*S*W\'0LP(G0%+1,#"FD2,8_
MQ1I#N:',9$^QK9R$5---.>W4TT]!#74U99K"H9[7MIR*OK.@,8BGCO3# :*5
MDH0*0%-%54@9(Z9C:5:#4OH!I)$V"&\L.$JJCK9+L<L5UO<8FRJK'"9ETM#V
M)+(6-PB'6M79;U73[]H+^8/*S/[<>A3<==EMU]V!Z+DSVK< 3'3_W@\5C0M-
M.[U"4\]W-=K2T@E=<DJH-0%.6.&%&6[8X8=]8LHB+%N+U2*T0,'I58W2PT')
MZ""B5MI,V8WF)EH_[M%7#> (,J.,-WB#+)E0>DAFV2;QRMN%.R87WW)]ILA.
MR]J"V.BU@):!R42?&C= @Z&^=Z)_CZ[:ZJM="U2KY$ ;.CX+R3/T7 B]F@3K
M?00N5+%+H1JCJ+/ACEONN>FN6[!,Q-Q9M66>EL%EL9[;2:.<FS+NNPW"Q"&'
MMQ-&EJ6#@.UU@R)(5@CFC9.*AD>0-Z I-CB+=IBW?(-F3*ZNI,73)83MEEO<
MK\0,NE *[:I*W=9QSUWWA*!IM#\/4Z?,%]"?*;(,=8I8OWJ\X6/_D>R)DM]=
M^NFI_Z_>^F]3I<CLUMC6&W"3C$TH9PJE8^D'J"@ZE6%]?DA)9>J.@ZX(SRU_
M"'.D8-Y<)]D0@ZIRA8,BO.)1ZE"0J534?%8O''CO>CP;GMHN-+L(4JV!%;2@
MN^ T)WV!J%'VFIW2"/:>K\AM&68BVF6:AH/M79"%+73A"V'HFDM1L#.CPXUO
MS.*X\ FD0XJ2E7?BUQ+U1&]A,,H!3E!6I>@$9WZZ<M58BO XP<%F/!7APM\4
M%JOX;(5,CZE= 2/#P!@ZZW6D$]"98+<M-$;M4E@<XQOAN*)X2?"+#UR/ZJ"6
M0JC!)0=NK-KRN,5!J- PCH4TY"$1^4:^H<^/AHF7"&]WE-8Z&*0. R$<P3AG
M$/2)H9$  XN2?E426I6O"#O4W$/& JS(S20VV<,!(=\EL<3XSE8#G(L 2_<6
M(B:24UJK)1CQ&#S9P9*7Q31F:WQ)%P_FDE%L;&87P1))JXWN:UZ4YC&QF4UM
M;C-A :R(^E23MHF(\2B.H\GXT+<U62&I1U&)QA_1][&<5&F4T#%6JU"IE/Q-
MYYVO 8M$5O@P<9W0@V3B5^RD)D@9D).;7GH=H:HIM!-&=';7;.A%,7J;-9JN
M5%RDURVA<E!\A;!LK1L?@$34O$YFE*4M_W7I2Q=D0XHP#C5X<XE9C+"2ST"F
M5&+(Y 8< !5P'JV$%BE"R@YG."/!07,K$4L42Q(LV(QOG%5#S!:YQA7@13!I
MVT(#3+V43(^>,756%!I(G=DLL*Z5K1RQ::5$N#41@?$Q< 5>5A23@]P)+*Z7
M66E; 1M8P0XV+Y-X#T,)$PVY6+0F14@G2"5##%XA59-<&>H?MS()_4'G?2PY
MT@;$(KD*2"EKY)EFA&0G-K3&IRO+W"5A%51&U=*5=H]5XVC^"EO='I.KM-.6
M&45:J3&%":^UY4INJP:CH(WALKMU[G.A&UV"2 HJ 3W-EMR"V)K8%$^<W$<T
MZJE*JO3S;'Q+E+&LY!E**T6'?D91QBIIA5S!D,HK\F676+.%P*TJ\T&/T:YT
M:4.)U7[0,GK\HER("6 %NU"67%S;U_JKT-Z";2H)QAK?-LB5!6^8PQW.:._>
MPUC R!8'2JD'=T$S!AMI)ZD;2-_<KGJ9[^3DLT9RE7T3XKAY"J<U5:P(CM<5
MJT1!=%OG%>%YC9PX'+S6P[$A<82?YB&[GG%$3;;R!1-'9+ -UZQT#)J]F$PW
MWMCKOU<V\YG_T:R[$C8%R'J)BX@S<F+C#F4,,@)B<8Z$ _+*;73G7>=*PELE
MB#31)W=&TLU8,YF*6!A@WMQO1"G553,^Y:MI_IP:3Q>[?)T0M1MDM*5!#;%%
MQ@DTG*:HV")=H64^A6+2ZU!F0QUK6<_Z:C$N<6I<N5"CO*X];5&Q0N @S^CX
MH+EQPR]%=D5C^#Z.T"!YKQ3;FYI_BL&Z1Z.F(+&-TH)INBFWLDN9:0V82SYM
MF6.MZ^_\%FYU&VVG\RJKNX/FELR@VS]=^33<;'EOZ2F#W\301";^G8E)9"(-
M A?XOS6A"6+P>QDT7??#(;X[7Z8F5F[QB4TI^NN%- 1^#VESPU"\_QCZF$R*
MT1FE=**]D<!%%;2LH>J2X>;H#?;'W&?=-!C#''&_V# N(IU0F+1EUTEY1=^%
MT<<R^*V,A2\\Z?OXN&[['? T3"(-:1A#&L10]:H/7.'\UKE9YLA,$1ZJN#6W
MRV^Y7;SK+2-#%ZR',OY==4Z3;JR*ROK %_YUO>^=W5"KMF'B"N=]</?F55Y(
MQI"8$T3C;GR5(@B4]!<<P\TSP3.6'WJ2$S<AY_)X_7*0IDW=&'#SW2P8-_6#
M(33EWPG^+_TFN)([*BA*51W@>7^NTE]/=_0UBD)WU\332:0,I!,#%/X&.,+]
MS73@@PMT'Y60.G_GDJ%KV2[_DQ[>E@\Q?A)K NO^J7L7'PMA"HT!X-DG_?G_
MT;\B<:J5,^+$0:4[PG."X> !+<](0T9)JSWC;J<"LN[*2>)]C*18]H\@ZF$Z
M@B/E.@.0*,+ZK&U@2FTB^$4^QL92)@+^TH\O>H;>]JB[T.653B,:B"'WZ$W\
MQ&^!)N'WBJVEE"$3W"_VL JAP 8JIL[K5@0:C,_JY&7W>% ]9J_VS ]2_LG(
M;HGZF.1T!&0TRDYG+,@!ZZ8%=7!"( Q:Y*/N+,2+M.?W .SHE [A#*[@N X(
M@S #R5!%],$JQC I>D8B8,6'S&H,-,%^-&(9RH<Z%D]WW \J%B(.D>175J8"
M-*$ ]\$..LO^4(,!TTWS>LWY?&Y;HF\B?JLN1J\,_X_BY<BN=.CD033(*UCO
M+'!/R8A'"@-)]N8C$]+P@N"NW780!FV)I'C**\CO%$T#][JOJZ1%!J@P]DBG
MX&P/@VZN><"/MH &3[SFQ2AQ5+C/%;WO+89P!VM)TG2Q(@K."5^*%OEJ&:G0
MMJXN$WKQ&+UQ3S#LQTYC0*:&8_;K)9SNB3("#DXB\0Z"&NLFUR2"_08"\E3I
M<(0-?%J-(91MBG"-Z.9&$U3OE[[OMM)(0!(EY[X1*> D],@*@OJ*+HI.+%KP
M&LU.PF(/]3YHR;AQFXCAU6PK(D4H](;QCL:I$T>%X.:L"B\D,\QHI&)1%E$$
MG;SL0I#,/YSGW,B%'A=R,/\TX>7J2%!0+R(-1@:+D.9H20S>@!C@49O^+0\I
MJ@>A;,F64B9[\BI9HW\FXC3^"7GV\)^B!:_J;" "YWX& C@DQRQU1Q].Z+5@
M1K0XBW/@H-56225VR#36YN^NAII@;][\,L.P8MN8T*6"(@;4(P8D0@9N !=Q
MP# E C%Q<3$GPC%E #(5DS$ITS(7<Q++@M<H,,/6B"Z<AVBRPBHUXB,CK""I
MK+5&L=QJ:QKWA.%D4_AF$^EH\S9M,S=K<S>M4ADL420')9#DC>S2S@VUQS33
MHB))4<HH0[_Z"BFA+!9S)1JR$=V6D,+61M4F3#*P<C!2T;@,+$V <P8]BC\*
M#*TEPC,+A83@J*X]I^X]W3,^X7,^Y5,^>3(PB.$-)BJ7JM-GXB(%N_\S0#=D
MW'"(,R3F/6A*(,VH+?0$%%+B+@>"Q2A+ =4,+&Z%:LJ22.Y1V&S,9I8! $=)
M$ N#)A72:&0I-$%#CU0'"T.C0%F*O@I&0F3TCF9T@0@C4#;J+2:0187I,>[3
M$VER!D.#MA9T)84KPL3 %-F$4'BP29WT29^4,SM"&7IH$0MHZ(IT%"'P%;E"
M"U\#-8DR*">M);&%HPS2O[RT4[QI";'4-9/CT3X$2W]40,\"-;EEW@9E"D$D
M<>Z%EE;4)=&41=(&2@FU4'FP,.PT3#_32(M30L0@3>DT4L^C2FVT,VZI-(@!
M#1X+3>!P(8CE#@4"GWS%$*L'1M4# P?BO2;_1R"(1+1&U>3*AP+4LC ZABKL
MQC-K4B@SC5Q.2$H/J8I4<^R"E:2:0B_YXJ$\,*N,YR$_SU'T NZXM*,J,$47
M5;]RU+@2 U)5Y!E9<VN:IEO!%5$8)86X<RRH=#R]3".%53BM-$0F040+0^DH
ME78R,1C+]+;89F!8DL[FU$W\M":Y;#PCLMQ<5%(]D5+=U([JK<O(!(V@CS0I
MS//P9!*0\S30(!=)$6,U-F._"3_?X$ZV3) 4R%KM=77ZU6!1%M>FXF3YHO_&
MB4J7,RIHR'%(*R%D)8FVPX+&#=D4 AJ@@R"@(=CP$1_K$CP.T27@M=9"LEK5
M RPE3$X:PS)*])A,_U7LK'9V?%4LCLTY63)+ZVXB/P)FQXZ#K#1"^I0#H=,*
MQTD35G!#Y+$FT=9!Q"(:=M8\O0PT]<C;'))Y+N80*;7F5C)'IW4[][,H;4LB
MTD 3Z.%/8 1-'I&9+G&/$DHB4]8L-$'10FAOSU$)2[:_8(^_'B1Q3R0/#;5T
MFW0B*I8@]*%6H[453TWL\ J7Y"(-4+)R;7<OSM B:K<L;(TH40J6V)&5;';'
M(")I=R>-B(@.G2HA2$[07/5(5F(?#0,14]=3,FA/@0FK\@MN!Y,%N?=[1X-E
MTT*V\E68YN_G'JAI9-(%2V4YX<UL0]$UKY. YH7(OD9)421PX[8FU^+TQF54
M0*@O%*&1JZK7(UH0RD967.%7@C823U14KL:68OM$BXJ'RD86I1X7RI3P=I7B
M@&N+6IWI6E.-:W52&(/3($,#WA[5X1($)%%'*L0UA@TWA6C8K"")+\2V]X0'
M3[VV")FUARD";/\Y>(C)HJC$T3 TV"(2#/)J5B"VQ+,, E2MQ[#>XF]^=B&B
M(7A%R1T["S7$28@51OXLPN?>HUZSBFM1:VJ-B>VN=G_[(VN1!H7/V'R_]9FZ
M%HSW<#^@=E$R>'+W."C[P]LF) T*F##^N(T1>7?W@1Y $D6UB@,=^5H%&8#O
M58WSXERY%S#1<V&9QWCX%E![JRD>=4\BUFO1;BAM\HPQ& 2)V">6 2AM25U[
MZX FMTSX%DES=( G)!.:LCE<UD^!DT<=!(^G5!4+*&VCEEE+L-X4EB+PMY6A
MN2]P5 R,=R\L](1'^2-X17@%0E.5)- *V5T4*RZ&"CAP@B,<1XGJL$?_FJTP
MF"5W,([SP/>1)0R.XPA8U2A@\QFD_E@C <18]^+)U"F3@3EQ%#DAH/5U4PM?
M@1B2%3I.2&<L281>+S$L*[KLYM=9?Z)W4?C(WE2/S59S$UAVPODK=^]61IH\
MYKGS2G@C YAL<" 3VO9$\/E.];>CC]"-^S::P]82=4^$,?$#@6;50M$ETO-W
MQ'=9_+.HGZ\*D]HGE&%0FQH)\PA;$[99W52/%)>GN5HM>*U@_X)NT?<Z9EHA
MCJIS!F*G_G!6I_AT]JQXXR\NV<E7=H)"^X)$=4=!0_.J@1J(P?JBJG:>Y]F>
MD4+ N/<\*R*G)?9KB/E-J.]SL51@'QFQ)Y='_Q$[;^TN+GS@H%M#4G0:;LM.
MBCU"IAY:F&]Z5Z,RA84"H/="K_MS*H'&D[<3TR+0&1=1D-_CF5<D4.I8<ID3
M$ROZ/R*Q5%B[J\4:I 4XN5WQ?=V42,^6;/39A&4:03I$GXF+GYLV"36R4LTB
MJGN#;S<1B$%W>+3LM^DB$ZJYJ]6[)@:5L'U"'V@R(HM[XSQ.("P&STC"KJOG
MJL)D9QQ">C-"'^Q G3G+((K#(/1;+6KUK^D&6>W62CWH@"995:IQN1&Y)N=[
M?%%-<>I7-!]C9),0-Y9/KQEVCBEDE1^2WO88Q >R2$NMI/=B:06;WC*<(# Y
MNUGKW2I8TXXZE46QE%J'HJR]VB^_C+98VG-WE?/B*E]3VH>V8JM7!!2QJKAF
MI\7KB&V$/)I;4%CYM$*(;/K(6TQUD7.7FE%2RKQU7 P2?#:N,6([5PDM.6PI
M>/X46B=IF3\[FE<3@[/_U[O/T08NGGHMEE,Q:EPABN.=0*<N@P.&NES#&.(A
M>IDL"SQ9!E Z&MO9D'9W8NRSNZC-@Z<JW'N,8/2"M?.B@QO,MR74?V(#X_<@
M1U@9AT*(H6%0ZWP4@[&OEWF!!7.LK8*0$X2R*9NAT^ZE;RTDVGS W'R6/_EK
MAK/;7%=[!.-R(W:/!?. :-MJZ9AX;MFC%,.#>#E%E(M%<<!.--DY-1=K_3PA
M!'+,PP9"B+#*-3FASAQ?;H583]MQT4?C[*/_DGC&=UIKRWQ<CE29G4_3^MVB
MQ7V!8#S=NS-WU:-ZRRC$C;'0# ('O<)Y*T"T&PA'+6)[H,J^1!7C\1LZ+ITC
M_ZA7>CA^VZD<PKMVVU4=AA"1]TQ0YFG^+0J]]$JX89T&<+>B=D^,V\WW@:8,
MWTG*RHOZTWD\<*']0(#YPDLV))2A*],SO-/$A,>[Y5,<1 (CJF^ EH"3Z&?N
M(.T%8FN224M[]ZHIFTU$H.G9:0^^X#-ZC?A<0*-^&7^<W1L:VR6L+N!JRG1U
MVS_D+N[CNN>%U*MZP\\\3,PU7\T^\)$=A)60.$V<DK$QIAG^\D&B&, 2.3<]
M-0.](!["T7! KE<BO:DGD/!")M8\(1 OJ5 F %5B P(Q+\1I[A?&FR"?0F9@
M[M;#31F<FXH!ZR'M@XE_=F^TW9,<<",(@=RBZ)3A8O_O'>MA.W9W<,4_#Y5A
M.X*(ON0)(U7\=TAQ*=A9LRAS*QH:G8&?,X(^%];9?]'".KX-2,8A,HG]OI/A
MM+GQO5'?S_83S8<!0@8.@0,+%A1#4" 7' <9)G0(\2!!A!'%[+N(,:/&C1P[
M>OP(,J3(D21+FCR),J7*E2P[3F((48Q$' LC"GQH4";!F@(I4IQID"9,G$1_
M#M1I,"'2GC:;-OUY4XRREE15IDD:$:M3K02Q$IS*LEXFG%AK\A3JM"?.LUQE
M<AV:-FO7FDFE5KV+-Z_>O7S[^OT+.+#@P80+&\:H*6<TOIJ0#D5J%,<8E10V
M5(!K.7,%RT4.>_[L]^71I,3]BFP&9;+(ALJ;*[#6#+O"YLJ:^B[-!#JW;I"9
M&)J-F3"'UK=H;\8=F&:W\N6%E8WNNM;W<1DZ'4>D.PGT6+EQ?T)]7AVZ3; E
MMQ=D2]2F6[4X?!K_#I>B^*!>MZ)_^W,A68*3EC%/"1=:;^T75'I9X4",2,K(
M!Y>!9T&U'DQG&=?6<PQ%:.!$A?5F'(5+6<A@<5L16*!TQ,UE(GWL5:<57>D9
ME]Q_>1U7T$YRN55?A-,U59N,/OX(9)#[$ /10P2N.!%[\V6H'E:.*45<B?!]
M*"5[[44W%&Y">C0&C49Z.>) Y*7D7(U7<D>B45TUE%Y^8;)YX)?U)=7CEG;>
MB?]GGGKNR6>?&(G64SUY+0A3D3")L0R19HY94FL0O3&;9:RAYF>E53EGH&H5
M4$J29;.UMH&DEFE0 :FE@KK9&XOA]497DUD*JT>:++DCA X]&:&;9\88:Z^&
ME3F33V;FI%"*T5&'57:?)6:KE<C*26N+$6DY$C1CD/CLF4!%&2V%6(I'UG!0
M3@04MB**06V?US;UX)KC/@7M0.ER66A4MUIX(K[%YJ0O<#6ZQ1.+ ]4)F#Y=
MSD=EE ;]5M=,V9;[)'<E'O7B=+BJB,.\OBK#)%,5#UMBMF+DX&Y%! GJ:\HJ
M,R?:5E).G*%C]XGHU S7W3SGP^ &2%W)PWX\!J-WIF'_X[T/.U43?$IUE:!*
M+_D<L'@AQALS<5'3J!]D3JG)4!I"KPQVV&*/37;9'!$-$Z\M*=.EF<@.%#1&
MHS%$,$G1L%90)G"TAJK99+=-U ^E<BJ2)JAF5H\RFO*MF:FD6@:'/E7->JO?
M?2;F+;S:,BDNSS"]:GGH(W&<K^>T&LB5QH0]O:.XX=DD7%$#-2V2HEMS+GN\
M!:VK+<R.0;9OMC-G3EQD:TZR*I^>+Y_US]9!F2Q(A+[W<UJ_1^NOU+CG"SI@
ME$,T89$1G[<\Y]SZ6US$.G>>?NF9CP'-RE>A.'?FWCWDYNEG.NN0VJ+_#\"-
ME(E"5Q/*Q[;GI-P9+2;YNA_2_TK$ENJ)CWT(VA,:6M<\FHW+.@:I&TF )4&?
MT>=!*9H2 J%S,0KEZ$@Q^5H 7PC#&,IPAAL!7,;6AC;BT.XB@#H*2I0AJ:[M
M(U*GVL ;:%@I8N"/( Z 7$E,0ZK'508CRC#"XX@8F\S P3\K411!N(C$_]CN
M.TIK75$ZAH8P G 9W3*4@-X4/JSXKS").1%22"8=<RW,*1[L2!V]-;Z@D)%
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M%/)F)4$) 1(2&X<#A79$H)!ID_*)+6$=DQ!=/U 0ZX1=AU,!)G%=2I<9KS&
M12 TI$,0J%>+'%%'")8_.T8?72!]/[:,A&%YPP9Y1]A6:M<7B9%NUO8RRF8U
M=-,1.<1PU%=XM-=>5WA7+":("K9'Z8A.KX,#]:8;T=<LX.A:P;<[&O%J/M-B
M9L*"']=,;B<0;H@S?L$A9_@8 R>/#!E".A)O;U=.$.=2[@@3HK@;."9*'+9D
M[65,]5B-0K9P7(9(>6=>7H@?YP-]>L06"*9C U9RO2.20))EO/=X;.%P\5$0
M/<4@(KA*T'**_[5NY@.3_WZH%1>(<7!B%R/IE,NH.*!R:.TD3S7"46R3<'21
MBB;Q:@5!?)8G!I)6 0RU-UGTE"CA@3BP#)H&$8\T7018*DR'$F)I*II!C.\'
M1OHD$&3XE MYA2"&/B"C0#\!AV=Y%\@XB(6X>M,H%QRHD)[5A;IG/[AC8VDY
MD2S)=S,94@CC9-\F>F_W%HZ9&_$1@PU4/721$?50:H$(CUP1.P-YF01!"7UA
MC@>"4^CD,B0%5T,%5S&636SE,1+9)A1RB#)":OS&=ZWI9^"6+X9)6X-5:A.I
M@M6C5\ 33F6$3<UV3/,A3L-6G)Y!<9\T;'H40K^T;0YH5S>X/MMC5AAV=N,)
MC_\%MR;PXYSUR7W1$!L5()<'M0PG!1;F]E8UQA+!AEX>H9K&H0EE>42A8E&6
M<43V*1('"A%IP!D/H6U0-Y4DT8L!F%UU60%%@!H1\9V=.%9=Q6ML"'P" 780
MBA=C=U[HV%H!8DT3*E]*14"P V[CHYL>-%8&UC /\Y)<I8'!MSYL@I(T8WTM
M):1,^7#R(B2"=W$GE&OBDA$+21$(1C]&^H"5]%[NZ&4229NL]R7W%$W]%:1C
M=H+VA6) <92&-54Y92M)21"B67QI1H]ZEWLV52CP%A,LFE*)=WQ%:B5MFJ/?
M!I X,Z1Z:IT_^IZ#J'CU@B-@> /V:!BUZ7EGZB$X06[_1":8!&=XJV6'*W9L
M&;:)DS5F+)@C?.FGJPIGIC%=E4$JGO9.>H8H+?.1^#1J;=41T' H-V0'E0$'
M ^6+LLJJ&O%3[9$98U$=0(==%(!%5"%IPYAI6"0;6<*BWX.1@BH^K20?IR@3
MA5FL +>=L(:'[GE"3!@:;!A(6M4=%90173F$"J2-N5>1!\F#!V2C2DFH76HE
M\D&IA[&#$3B<UT1]_^F#7>J>4I4_:Z5Z2JE* C&B)8&5.[A)V!F8S58Q1RJE
M\VJ#$O2BOI0G[L6H1-B13YA0_QJNH4,H4P5--RB9$%F1%I):)"N/L$EF#7F=
M*N2N_]$E4P@BC\I:4H4<'#%6&'J*+U>*?);4L)*9:URJFU (IVJ6%*>7LO]5
MBUR%AK6;L9\'M9"7A[(?(:$XR!&)%R.]" JNZJQO:;4;H2B1E;;[8!XPIQ&N
MBBH/2A6:H'34.H"7P8V?V$WZ9B$D,Y-;2H5]N[;^F#W"&:A$B50%NBPGRJV=
MR8X",2]MHX[1 I-)L7FV1R[O0GB+ZK/X^I#\9G$R0*>& :7R2I EQYTWT2/&
M=Y&A1*IMB)[V=:@,P1=#^9,?N9A=J%4<U+JNY"ZH%KJ:Z7<]&"=<AZZ[H0]-
M^A#&%E,SX+ VFU^'BT0V-"!-FTT8F:36([BF9:(%L8>&"A'$VR3]4KHMN4\R
M8H[&BY#"81!Y)1/06S1_E1&N*)\FIXW:21Q=6'K_+J.Q,KICX&J]!3Q#0'27
MJ1)8ECLQ,O&U(8$A<Y1BO"*6=I"?&["UUAL@.6 9%Z%),J VA/:6M(@7%BR
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M0@Y(TI<98A3SF)R.F3WP*$'(XRH99#>)J <:U&Z$28 7=1F)O@.PR'B^CN%
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M&F&8>L@,TWT("$W-Z%"&G)-29N*YOE0]NZU#'H0W5ILH-)C=X550*+2>F.K
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MRT[&'0DA#M5#))M?%9AR9#[%0I10$5MDA@ZCY+<.E61_F>3D.%POY.$4U"X
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MA&)[TZM/8-WTJ8\\^M*?_GE D4T,*O!&%7C#F^@HAFQ7:Z@#F?U$>'+S_%"
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M1[+M&+7)$Z:9782]X4# W.040SQA4B4AHI&!1.>I7R5:XB5>A/6Q&9M16<[
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M'YKE<E4.V;M>'-%W>/NR%3L^E+LD1(A"24RGG_,H OMZ9-IS^A EC\._S]K
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MMWC[H#;_U%5VE,41H1<4XR6 ^D=0[',^^@-AP ,Y#<@QI81R$%AD>,9B#+A
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M,)NSY148ON>PZ T#%40[ JM<K(IE+0Z\D-N!CH2"?H6X,=ZLK::/! DC@M9
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M0=5$ SU$0STL6-V=UQ6#0D&3UP??A0^,X[)FH(!]7:"L;NLJPS)4=$6DDF+
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M5.:3%Y;?J^DW#VM-S.N$Z<2N;<9BQ.Y:T^XN'3KEI-][6V<^E42L\[@'%_C
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M%L C@^/$)%P@Z38*WP82:94L@WX'<8"M;H7)9;&[-AN8=TI\37F7% %V[JY
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M)Q"?"6UWKH&01^-I97*(U'9>?X4BJ?LWKY-,16-]/$)1^U898Z1A)/8]&Q6
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M;CBT>F3B:R#\S;@@M12M.<56U.N0WNX$-3UID&T3-,X86GA$V&1'*F&28EV
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-/O6J7SWK6Z^]@   .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>fgen-20230829.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-08-29T17:12:05.4530+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.fibrogen.com/20230829" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:fgen="http://www.fibrogen.com/20230829" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" namespace="http://fasb.org/us-gaap/2023"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fgen-20230829_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fgen-20230829_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>
      <link:roleType roleURI="http://www.fibrogen.com/20230829/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>fgen-20230829_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-08-29T17:12:05.4230+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Act File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>fgen-20230829_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-08-29T17:12:05.4159+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.fibrogen.com/20230829/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="fgen-20230829.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.fibrogen.com/20230829/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10130.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10020.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10000.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10090.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10100.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10120.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10110.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10040.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10050.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10060.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10030.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10080.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10140.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10190.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10180.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10210.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10340.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10170.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10220.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10160.0" priority="2" use="optional"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139913608810176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 29, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 29,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">FIBROGEN, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000921299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Securities Act File Number</a></td>
<td class="text">001-36740<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0357827<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">409 Illinois Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Francisco<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">978-1200 <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">FGEN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>fgen-20230829_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="fgen-20230829.xsd" xlink:type="simple"/>
    <context id="C_d206cde4-4b9b-485e-8579-ab78929ad8a9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000921299</identifier>
        </entity>
        <period>
            <startDate>2023-08-29</startDate>
            <endDate>2023-08-29</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9"
      id="F_beb34137-bb04-4096-aa07-7311cadeb5a7">0000921299</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9"
      id="F_a7453f1c-9db3-4812-b92c-e02400149aac">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9"
      id="F_4ef35b19-b843-44e9-8b2d-e167e98e1ab3">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9"
      id="F_524b0d53-1ce6-4f06-b8ee-d906c5c9ec87">2023-08-29</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9"
      id="F_03a3d11d-ecf8-48e5-acb9-fc81e768078a">FIBROGEN, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9"
      id="F_2e2c95ea-1657-41a7-86ee-ee62e60ef440">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9"
      id="F_33357f6a-7b97-4aaa-82cb-5b9c59f64da3">001-36740</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9"
      id="F_ad69a749-17e8-4a12-8755-71d5b18d841c">77-0357827</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9"
      id="F_a2fd74d1-8699-426f-818a-653079268244">409 Illinois Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9"
      id="F_9810c3fb-fb26-4c41-8b2e-c16c3f3a2042">San Francisco</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9"
      id="F_8a4b0c5a-4de8-41a6-857d-4bcde7089082">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9"
      id="F_1384b403-87c4-43ed-9f41-12e3b1efc70d">94158</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9"
      id="F_14629135-9e2a-44f6-8210-1960e193941f">415</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9"
      id="F_9312dff3-89cb-4b31-b34a-00c07af1b760">978-1200 </dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9"
      id="F_57b17cc0-29a6-4723-8ed3-2404c0a1f3a7">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9"
      id="F_abe58744-cf71-458d-adf3-8fc384c1d097">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9"
      id="F_a26eeb9c-c69b-42ac-a9d3-8208e7659fa8">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9"
      id="F_460923e6-d8a5-41d8-845a-d48a02ce58cb">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9"
      id="F_b2860430-d1cb-4743-bdbe-80466844fcfd">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9"
      id="F_5eb61462-ba3e-4b01-93d5-c0fd1bfd9d84">FGEN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9"
      id="F_af9f164b-bd45-43ae-8763-98acb6747dfb">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_d206cde4-4b9b-485e-8579-ab78929ad8a9"
      id="F_dd5b44da-e1cc-4be7-8f72-3519f2549845">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M-^2!8ECFS_A[QA?_&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @
MRXD=5P=!36*!    L0   !               ( !     &1O8U!R;W!S+V%P
M<"YX;6Q02P$"% ,4    " #+B1U7UYVDYN\    K @  $0
M@ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " #+B1U7F5R<(Q &
M  "<)P  $P              @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+
M 0(4 Q0    ( ,N)'5?:(LL4600  *@0   8              " @0X(  !X
M;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " #+B1U7GZ ;\+$"
M  #B#   #0              @ &=#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0
M   ( ,N)'5>7BKL<P    !,"   +              "  7D/  !?<F5L<R\N
M<F5L<U!+ 0(4 Q0    ( ,N)'5<ZJJ+G0 $  #P"   /              "
M 6(0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #+B1U7)!Z;HJT   #X
M 0  &@              @ '/$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E
M;'-02P$"% ,4    " #+B1U799!YDAD!  #/ P  $P              @ &T
L$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #^$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="fgen-20230829.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fibrogen.com/20230829/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="fgen-20230829.htm">fgen-20230829.htm</File>
    <File>fgen-20230829.xsd</File>
    <File>fgen-20230829_lab.xml</File>
    <File>fgen-20230829_pre.xml</File>
    <File>fgen-ex99_1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "fgen-20230829.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "fgen-20230829.htm"
     ]
    },
    "labelLink": {
     "local": [
      "fgen-20230829_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "fgen-20230829_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "fgen-20230829.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "fgen",
   "nsuri": "http://www.fibrogen.com/20230829",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "fgen-20230829.htm",
      "contextRef": "C_d206cde4-4b9b-485e-8579-ab78929ad8a9",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document And Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.fibrogen.com/20230829/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "fgen-20230829.htm",
      "contextRef": "C_d206cde4-4b9b-485e-8579-ab78929ad8a9",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.fibrogen.com/20230829/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.fibrogen.com/20230829/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.fibrogen.com/20230829/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.fibrogen.com/20230829/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.fibrogen.com/20230829/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.fibrogen.com/20230829/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.fibrogen.com/20230829/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.fibrogen.com/20230829/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.fibrogen.com/20230829/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.fibrogen.com/20230829/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Securities Act File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.fibrogen.com/20230829/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.fibrogen.com/20230829/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.fibrogen.com/20230829/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.fibrogen.com/20230829/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.fibrogen.com/20230829/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.fibrogen.com/20230829/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.fibrogen.com/20230829/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.fibrogen.com/20230829/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.fibrogen.com/20230829/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.fibrogen.com/20230829/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.fibrogen.com/20230829/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.fibrogen.com/20230829/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0000950170-23-045111-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-23-045111-xbrl.zip
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MP<A1),)PBDYE1",F:8@&U9 ',$?61,=AB"[45RFZ$*E(K@5OJBY_.1IF  N
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M I\EYTE\+?-Z"#L>[NZ E($E1I)N25#P#47QYB4\O3E&"E"]6WU)#-?T3<W
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MZ!N7PU=S]BMR]F5"%?;*Z\VF(QAL;_-2;VNVKMFZ9NL7*^Q^6>D[U]>B<E_
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MOE7M>8T>'-C6T#G6C:6Y9,Y^ U!+ P04    " #+B1U7S+==%Z$%   %,@
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M3?O0 ?Y/DO)9XTZ1TZRMHI+4,ULLM_;2-FEKILBNK:(3N6\FK_5SR-O/F;-
M^TG6[B#;SO35-]I.)^F9POIN_B69?19Y'VHNK:0JD F\KKG _5I"INJ/FJLZ
M4XS(A'ZLN=##TD6FK+[WKS-UCTSB36TE'M=*LM.@OEOF^6)+IK*^5[)3U9E,
M7WU]\[BHLU/EUO>F4EP5VBEKUC?JBDI*F1_6]X [J$AE3EC?A*"DJI6MUO?=
MNVZM(V68\GZ[N]HVZ _];YF[_P!02P,$%     @ RXD=5[R.I4;<#P  /V8
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MX*TB67Q4VMJE194:^XI@L\2RT:I@Q?R>6%[G*>T&03L#>ACTF?6SL8WZ5TL
MV:%FKJRNE]/U&AQ9 _2[%>O6&^S635MKK:S'91D"48G'[W%H<' 2(4I%:&AY
MZ0&#L#WC 1*78'P%:$J<V^N@V0G=)V.(@K9G.,F"O1?.R2G9%9Q>F;.#3(J4
M'5V*N'+R0K W:2IC83JM"0)07Q-S2BPKK51K.6)=&3X5NK),I'CH[#*>=*@-
M@1C>G6(($YXPGESHF,< 0IWG5>&!C5 IV"(R5+*X *C(*6$[8"G3+.,7-%R!
M[Z/*JT>CO00L-1%$PLK@PWLM0?I::AI%NOH=FW$CBRF@2C$EN"GPP3:F$]V%
M\3T0DCBMT6M%]9)FNA3M IDPC"PL;1H;GN>PTYE0)4LK!]QOU0,1$D%X7B[,
MKJWUB>'Q'0>&.Q(1NP%&0_2:Q7P,@+K6$+%1UA>+IV\-6!2^)!0DYQ#GU'-B
MF^E9@Z7EI[J3-5/-^6_:T,D'M"VHLLB%F=(O0#,@&T[X1>!0A >82<)PIG.=
M^*ZHI^;-;OLF38F@<U4/.L*W%Q =M.MI;_3M%9Y64['E"=%2E7X.P][3U:T#
MTPTM>VN]]SXWU_*8(_!?Q#%L@_!RL>V,CD7P0F#;5!5LFS?UY* UYRH+3FP'
MK\6JHDP@TV1;&<W EB*6J<1I:!VJ3K"DH#*Y=^GP?@%E0FVBM"T_P>#@+'E]
MD ]T7O)B3B>A\):X-NHQ3JAO#FJCF*FS!;54-]@7D 2.457B99(R%XDG'1BR
MRC=.S^;LK_?9OQX1OR]U3B)=N:7#\M4I]N$.[*0.90&0?ABQ2,_K0,U2I.[P
M]2&#'V;9]P1KWRDW'@S9'.Y-S29$8;12@4U<38!.E8ZXZC0QPPXSX!! M@\B
MZ;!$5Y$2W0B.5;(ZA B<;7@%N@8D1N!@/J[D1;PC!K@JV.?:V"!QM*4YIE41
M^YY7A-+N,S3X/D3A(.*J.![WG6'PV]ZK#1A:!-GL(POG/08+MA[@\CFU(S<'
M#?.^-G2KC$\W89EI9"F!"-T(RW_>Y2F6>(^K&9_;37'55VCV'^XP$F !*U]>
M-2P+#"+SDVA"3 ]'R\9C:[3+\NG.^92]_)621X=\S@8>T. ) W7=+"1J;(BR
M^4T<>E'<.M\KL?$:>+>7C-&:N+?WE@!^*-:VQDCZ^,CO1^K"V"JK^N>>\\^R
M./N1>;Y^4_G4Y;H[DRU!],"$38@*)B*22M91^4)48'[MBR%&'P*,/$U%3!RQ
M!"&[!+5U0A&B@6H%0-OM]/M]]#"+M"D\DP=RALTS[/OOXDRJQ(@B9(4DGQ8+
MZ"22'^@Z>A4\SCS#KZETRHG2-N) _IA7-G!D[B.=H-^8KPOD7 GN0RP^B8))
M1M:GN@&@B: Y$(UL="*)9!+%= (3*01%<X@34XPEK)'7HQ(M0Z]%:GM=[JL-
MK^#7^K49&$J!3CO- Z*Y'992+,E*&RBN+%+%\YR'_M]>K4P@[X=BIC 0<#PR
M(12XMS3 &RI$B$1*1-]/=.K%&0S;A),T(4B$\2D)=DTDG\8A97DR7H=KFX@/
MWH-WE%M,2=51+4W3*Z4)C@<-$7.#98SKCN\O/O2%6X1-!N>K,Y]+U7[KH=8O
M@IY?*6,GJU9J^H9".:DTEM39C4&G\16>^GLZD?#9YY"E#B:DC>L[BO-D,I*A
M-($#[R_J$#[&A''PI01.6EM1N8"> 9Y3M(*MV#HX>W&\3;:$PNXP0O5S& (/
M]62@ZF"&DBFES:@K6#1M$F$LA5,,WL!L/P2A2CR5UOD<'/D,EW$-XA:@:T*6
M 58YYD4+X=I,J;AK;MM@$KV9<JDJ0TFZ:]J":$TM75M<4.O%AY/N*J"[DV@$
M,Z1T[&TZ3RZX+^NK"I@1Z)+#OL!C*F+JGZ)H]#4T^6KR]F"[L8NUB,.=T6IY
M<N%"24%\LZN>-]3_ZIWVV+'6B>_QT%13-DFPH:!<$_A"1NE2PWU=RAM34BC)
M-SL4%B<EM(%Z;Q07+LM1WK39M-K710K3.B8'[PSK?0Z%?WR,Z_-=/0ZI[%-F
MZTO9FBF_(W;Q%F:?.P-!#VN6==?L[Y3LVHZC<1.!H^$EP;B\R65[LN+3TIZ)
MSNF0I%+5O)/>LU5)(4"\I(NIILW?[MA%,0T)B@V#D3M>(4'7']\@UP&DN-H?
MG0A2(75$-4F>^U+>FC0 @#T7GAD1#2WF8$?3YFSPRF4^K4Z+02B0$@:&,^GM
M@:[,%9524%@"OTOEE7\A+4!H-IOUFHGZ +7M3?7%FKC_=Y.8P7#0:?_;4)DO
M*!/66,SU)_Q?W\H_?/U#7;WO"5<D8>\Y1HQ%Y3P@QW4=PI7"1!"=&,!)O*73
MD S_N_<BT5*8&,+(#[YZD96R#)DGV)5K1(Z"I;ST@]EKE0] 9T48ZHM& ;7"
MCP?J!"X%TB9"$N^/\#B:EM+3NAQR7NI+R6FS5+$DTM*T_>?+8TJW-=0&_1?Z
M(C [[T9C!G:UL:P*V"4&"7VV<,D*$8.D0HTYR_"Q\+RU2S(Q6$X=*V^3&C+;
MJ6G<'Z=OGTO&/F9%PR)^"C'$E-_I2YY4U"7;6K^8VV<FK"Y_&(X&8_KY9%?0
MS]W1[FAE9>L#3N^"-CM6N48>4"=AEN;\M-=_TE_Z9W!?]28_//E_S_0!(*[#
MCGY]=W3RGS=?PZ*=O7[\"^:CV7%E##ZJ^8*@ Q4/,EEP+&@%Y!$=]A,'<@6L
M*BK8&PIVAB*\&),%O;X-JWDA<LE]CS\?+MP<3?>HN)I;[S<$_V#IV56,NP.G
M@9>Y#I9M'NP,^4=AW*V#EY/M=C[HM@U7&!&'6</"00*:M:-X+?PW$V=U<'\Q
M$'E0J592ASB'K^,@5PNC^3A"(A/X96WMA*3J0=W511Q,H5]>>([PP.H*G8*B
M$JKR40DE(0M,+,WF^$5W-'SR/8GJJX3]]8'6 >K<]'%\A&0JBAZ8P*,H,EQK
M4KE1UJ:>95//\IA=N(?RA@'',VZ2[BNMS\DS.H5I$OZ.UOH[\E_=)G@X1#ZC
MNWA&!"M,C[DL//?QFT/5F\.VFX,"FY3HQ<.&>X1;>\_&EH5H[A2^:'T7,-P_
MJ',==+>AOBIYA8M<=_MY4]X9[EUZ?WXQQDV2$GI<9'N6(LF";GK2_<LFBHQ>
MPS72FYTT]S(7'4D,'2H$%F2-.QXB#8'?W*:EFE)U6%0YG[$G1DCWMD(,I+/<
MEE\)HRW-M%6>CGX+<8KPT<U+6;ON1*=HNX<[(]&<5=9/DFZ+4*B<J)]M+[?F
M?+ZX,-L\G$FEFH>=]JG-=*62FZTI 4#)BIO?Q*M?H(A+[&X^I]G=?$K1C%B"
M5XN;WT5"26R;%4/@'.8K7\%A2N3*T9M%7C4/?%%4HOV"5&ZQ=!2\F&F3T%Y1
M#OJ99LSJ_*/[@!8(&C"ADKKY6PO@Z;T5"X[-5O'%M1RJR AO,)H='6PL>7V!
M5_L05N)O]"0U3?_XEDPJ7UEMI#T/VXC^L(:A\^[(W?&E'<UMXP %I(6D+1H)
M6T_ZJT#U,;K@H4ZDOGQDE^\T42>A&+\]Y&;YKY,UR1L/#HM,;<"-]KR%3$<X
MG,%!@RH<)4E#'9*_46YC(Z.@!4JE3(J"U/A.D)-#;AA,74[EWS^W/ETJ+?5.
M5454\8YW#^$_Y1'Z'PW\WRP9AB'1W2\5-Q@1JK_9XR]MC[^'5G5O/U6%8*-^
M^.LGG5#"A'-($)0LKER?"CBKTFN?!CNZK&O\#RA::BVAX-;I$87<KJJ5EK".
M.^*,"^\VABZ-D(4O4:6\%7WK;X7SBA!5!+>4TG=4.HKEIQU!MTE]O%+?O84Z
M#(8*,P&0\W.\0 !DE^ZT!>19,BAUAK/Q43$B;;ASS+?0 #759.H@4U7Z#BAT
M>ZL 89M+VF^T']M!*!]>.I+%B-\K65^84'SV:+)C&T[UY1#K R)1(#I[&XT^
M2*YIK=6Z9NQ^<ZKO2Y.M2?WZCO4#EJ?S"TG4ZU4%SZ_##HXG&^7>FW)_E6!U
M;\&4O(,([6H#^DHDZ_CM=SPOQQ//SIJ-#78;+EK:S1K<VQHDB5"TM_^^G-58
M:_VNF0(W!NR^-/F:BCHWQNL>%0I7F O%3C]0!IEO-'MOFCVZ=,)0;=-!^U=K
M-G;I7C6<V[!IU] N/>;<[/X.5>(]_\O^CO\?Q_P/4$L! A0#%     @ RXD=
M5^4\=! G$P  2]\  !$              ( !     &9G96XM,C R,S X,CDN
M:'1M4$L! A0#%     @ RXD=5Y6_##@. P  I D  !$              ( !
M5A,  &9G96XM,C R,S X,CDN>'-D4$L! A0#%     @ RXD=5\RW71>A!0
M!3(  !4              ( !DQ8  &9G96XM,C R,S X,CE?;&%B+GAM;%!+
M 0(4 Q0    ( ,N)'5<2N@MZA@0  .PD   5              "  6<<  !F
M9V5N+3(P,C,P.#(Y7W!R92YX;6Q02P$"% ,4    " #+B1U7O(ZE1MP/   _
M9@  #P              @ $@(0  9F=E;BUE>#DY7S$N:'1M4$L%!@     %
-  4 00$  "DQ      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
